References
These following companies are teo's partners in current and former projects:
Remon Medical Technologies develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. Remon´s unique platform has broad applications for patient management, post-operative monitoring, nerve and tissue stimulation, local drug delivery and drug development.
OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense next generation products target non-invasive monitoring of blood glucose in the hospital and for home use.
Mazor Surgical Technologies is dedicated to research, development production, marketing and sales of innovative medical devices for surgical procedures. Mazor´s proprietary technology enables a safer environment for patients, surgeons and OR staff, by utilizing miniature robotic, imaging and implant technologies.
Deep Breeze is dedicated to introducing vibration response imaging into the medical world of medicine, and to becoming a world leader in functional imaging of pulmonary pathologies.
E-Pill Pharma has developed a novel oral drug delivery platform that replaces drug delivery by injection. Combining effective drug administration with ease of use, E-Pill Pharma´s novel medical device platform is especially well suited to administering peptides, large molecule drugs, and small molecule, low bioavailability drugs, such as insulin, growth hormone, LMW Heparin, PTH, interferon and EPO in pill form.
ES Vascular has developed highly advanced surgical stapling devices for open aortic surgery, endovascular surgery and critical limb ischemia. These innovative devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions.
Impliant is engaged in the development of novel spine arthroplasty solutions for motion preservation. The company´s management team has extensive experience in commercializing new technologies, including fusion and total disc replacement devices.
InsuLine´s mission is to develop and market technologies to improve the clinical effectiveness of devices and drugs for type I and II diabetes. To date, the company has conducted over 100 human clinical studies to demonstrate the safety and effectiveness of the first generation InsuPatch device. The product has already received a CE mark for marketing in the EU, and the company is now seeking FDA approval for it. InsuLine has filed several patents that protect the technology and related devices and methods.
LycoRed supplies natural carotenoids and a wide range of other nutritional ingredients to the dietary supplement and functional industries, internationally. Over the years, LycoRed acquired Nutriblend and Biodar, whose expertise is now fully integrated with that of LycoRed. This merger of experience has allowed expansion into the production of microencapsulated ingredients, vitamin and mineral premixes and integrated fortification solutions.
Nicast develops implantable medical devices made of electrospun polymer nanofabrics for a wide range of applications. Nicast´s first two products, the Avflo vascular access graft and NovaMesh ventral hernia mesh demonstrate the versatility of electrospun nanofabric as a biomaterial from which medical devices with superior properties can be made. The AVflo is intended for patients with end stage renal failure who must undergo hemodialysis treatment. NovaMesh is intended to repair ventral hernias.
Optonol develops, manufactures and commercializes miniature surgical implants. Its first product in this area was a unique microscopic implant that redefined the surgical treatment for patients with medically uncontrolled glaucoma.
ProteRec is introducing a cost-effective technology that transforms catalytic reactions into more efficient biocatalytic ones, and defining a new line of products for chemical-based industries that are more specific, less wasteful and less damaging the environment.
SPO Medical is a leading specialist in the field of pulse oximetry to monitor blood oxygen saturation and heart rate. SPO is at the forefront of science, developing a unique state-of-the-art patented, non-invasive reflectance technology that provides a cutting edge, rapid and reliable mobile response.
